GLP-1 receptors in the hypothalamus, brainstem, and reward pathways modulate eating behavior at multiple levels
This is especially relevant when cost optimization matters, since wasted medication in the syringe hub is wasted money
In one study, participants taking Semaglutide lost an average of 15% of their body weight over a period of one year, a substantial amount compared to placebo groups
In addition to the above findings, several studies have shown that GLP-1RA therapy results in larger proportions of patients achieving 5% and 10% body weight loss than with placebo (Table 1)
Delayed gastric emptying means your stomach needs more time to process intake
This blood pressure reduction can be beneficial for weight loss and cardiovascular health, but it means your existing blood pressure medication doses might need adjustment to prevent excessive drops